Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00296465 · ClinicalTrials.gov registry record · Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
A Phase 2 study, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 132
- Enrollment target
NCT00296465: Completed Phase 2 study, sponsored by Ferring Pharmaceuticals.
NCT00296465 is a Phase 2 study that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 132 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00296465, a Phase 2 study, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 132 participants
- Enrollment target
Study Summary
This study will be performed in approximately 132 women with anovulatory/oligoovulatory infertility.
Interventions
- DRUG Clomiphene Citrate
- DRUG Pulsatile gonadotropin-releasing hormone (GnRH)
- DRUG Placebo Pulsatile GnRH
- DRUG Placebo Clomiphene Citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2005-02 |
| Est. Completion | 2005-11 |
| Phase | Phase 2 |
What the finished NCT00296465 record still lists
NCT00296465 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 4 interventions - of which Clomiphene Citrate is the first listed.
NCT00296465 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00296465 about?
NCT00296465 is a clinical study titled "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH". This study will be performed in approximately 132 women with anovulatory/oligoovulatory infertility.
What is the current status of trial NCT00296465?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 132 participants. The study started on 2005-02. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00296465?
The interventions under investigation include: Clomiphene Citrate (DRUG), Pulsatile gonadotropin-releasing hormone (GnRH) (DRUG), Placebo Pulsatile GnRH (DRUG), Placebo Clomiphene Citrate (DRUG).
Who is sponsoring clinical trial NCT00296465?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00296465's enrollment target sits among peer trials
132 539th of 2000 higher than 1,460 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia